Werkgroep Cardiologische centra Nederland English

Ivabradine MR CAD (Klaar)

Safety of oral chronic administration of ivabradine modified release formulation compared to ivabradine immediate release formulation, in patients with stable coronary artery disease. A 6 to 12-month randomised double blind parallel groups multicentre study.

Middel
Ivabradine MR
Populatie
stabiele angina pectoris
Fase
III
Jaar aanvang
2012
Meer informatie
ClinicalTrialsRegister.eu